Quark Subsidiary to Head Israeli RNAi Consortium

According to Quark, the intellectual property and technologies developed by the consortium will remain with its subsidiary.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.